Pearson M G, Ogilvie C
Thorax. 1983 Feb;38(2):134-7. doi: 10.1136/thx.38.2.134.
From 1967 to 1972 12 patients were operated on for emphysematous bullae in the Liverpool regional cardiothoracic centre. The patient with the poorest lung function died in the immediate postoperative period but the remainder survived for more than five years. All but one of the survivors showed evidence of benefit three to six months after surgery and all those not retired returned to full-time employment for at least five years. Nine patients were reviewed 5-10 years after surgery. These all reported a gradual return of dyspnoea, which was matched by a falling one-second forced expiratory volume (FEV1) (mean fall 82 ml a year); but five were still maintaining some of their postoperative improvement. When mean preoperative lung function values were compared with the values obtained 5-10 years later there was still a significant improvement in forced vital capacity; but FEV1, residual volume, transfer coefficient, and arterial oxygen and carbon dioxide tensions were unchanged. Chest radiographs showed no new bullae or (except in one case) any increase in size of pre-existing bullae. We conclude that the removal of large emphysematous bullae did not hasten the progress of the underlying emphysema and that in most patients some benefit lasted for more than five years after the operation. Patients treated by lobectomy fared at least as well as those treated by bullectomy alone. It may be relevant to the relatively good progress of patients in this series that only three had suffered from chronic bronchitis before operation or smoked after operation, all but two had bullae occupying half or more of one hemithorax, and none had hypercapnia.
1967年至1972年间,12例患有肺气肿大疱的患者在利物浦地区心胸中心接受了手术。肺功能最差的患者在术后即刻死亡,但其余患者存活超过了5年。除1名幸存者外,其他所有幸存者在术后3至6个月均显示出受益的迹象,所有未退休的患者都恢复了全职工作至少5年。9例患者在术后5至10年接受了复查。他们均报告呼吸困难逐渐复发,同时一秒用力呼气量(FEV1)下降(平均每年下降82毫升);但仍有5例患者维持着术后的部分改善。将术前平均肺功能值与5至10年后获得的值进行比较时,用力肺活量仍有显著改善;但FEV1、残气量、转移系数以及动脉血氧和二氧化碳张力均未改变。胸部X线片显示没有新的大疱形成,或(除1例患者外)原有大疱的大小没有增加。我们得出结论,切除大的肺气肿大疱并不会加速潜在肺气肿的进展,并且在大多数患者中,术后一些益处可持续超过5年。接受肺叶切除术治疗的患者至少与仅接受大疱切除术治疗的患者情况一样好。本系列患者预后相对较好可能与以下因素有关:术前仅有3例患有慢性支气管炎或术后仍吸烟,除2例患者外,所有患者的大疱占据一侧胸腔的一半或更多,且无一例出现高碳酸血症。